X
Please Wait
Applying Filters...
01 AZURITY (5)
01 TABLET, ORALLY DISINTEGRATING;ORAL (5)
01 DISCN (1)
02 RX (4)
01 EVEKEO ODT (5)
01 Yes (5)
19
Azurity Pharma, based in U.S.A, is a pharmaceutical company.
One of their notable products is AMPHETAMINE SULFATE, with a corresponding application number 209905.
Regulatory Information RX
With a dosage strength 15MG
Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL
Reference Listed Drug Yes
Approved since 2019-01-30
18
Azurity Pharma, based in U.S.A, is a pharmaceutical company.
One of their notable products is AMPHETAMINE SULFATE, with a corresponding application number 209905.
Regulatory Information RX
With a dosage strength 5MG
Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL
Reference Listed Drug Yes
Approved since 2019-01-30
17
Azurity Pharma, based in U.S.A, is a pharmaceutical company.
One of their notable products is AMPHETAMINE SULFATE, with a corresponding application number 209905.
Regulatory Information RX
With a dosage strength 20MG
Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL
Reference Listed Drug Yes
Approved since 2019-01-30
16
Azurity Pharma, based in U.S.A, is a pharmaceutical company.
One of their notable products is AMPHETAMINE SULFATE, with a corresponding application number 209905.
Regulatory Information RX
With a dosage strength 10MG
Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL
Reference Listed Drug Yes
Approved since 2019-01-30
15
Azurity Pharma, based in U.S.A, is a pharmaceutical company.
One of their notable products is AMPHETAMINE SULFATE, with a corresponding application number 209905.
Regulatory Information DISCN
With a dosage strength 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL
Reference Listed Drug Yes
Approved since 2021-04-16
Market Place
